Global Biopharmaceutical Analytical Testing Services Market 2018-2022
出 版 商：Technavio
出版日期：2018/07/23
頁 數：108頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
About Biopharmaceutical Analytical Testing Services
Analytical testing services are a critical part of all steps in biopharmaceutical development and manufacturing. The quantitative and qualitative results produced from validated analytical testing services provide information to control and ensure the regulatory standard of raw materials, intermediaries, and finished products.
Technavio’s analysts forecast the global biopharmaceutical analytical testing services market to grow at a CAGR of 8.98% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global biopharmaceutical analytical testing services market for 2018-2022. To calculate the market size, the report considers the revenue generated from the analytical testing services for biopharmaceutical and biotechnology companies, and contract research organizations (CROs).
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Biopharmaceutical Analytical Testing Services Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Catalent
‧ Charles River
‧ Eurofins Scientific
‧ Merck KGaA
‧ SGS
Market driver
‧ Increase in demand for mAbs
‧ For a full, detailed list, view our report
Market challenge
‧ Shortage of trained professionals
‧ For a full, detailed list, view our report
Market trend
‧ Rise in production of vaccines
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Analytical testing services are a critical part of all steps in biopharmaceutical development and manufacturing. The quantitative and qualitative results produced from validated analytical testing services provide information to control and ensure the regulatory standard of raw materials, intermediaries, and finished products.
Technavio’s analysts forecast the global biopharmaceutical analytical testing services market to grow at a CAGR of 8.98% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global biopharmaceutical analytical testing services market for 2018-2022. To calculate the market size, the report considers the revenue generated from the analytical testing services for biopharmaceutical and biotechnology companies, and contract research organizations (CROs).
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Biopharmaceutical Analytical Testing Services Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Catalent
‧ Charles River
‧ Eurofins Scientific
‧ Merck KGaA
‧ SGS
Market driver
‧ Increase in demand for mAbs
‧ For a full, detailed list, view our report
Market challenge
‧ Shortage of trained professionals
‧ For a full, detailed list, view our report
Market trend
‧ Rise in production of vaccines
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
‧ Segmentation by end-user
‧ Comparison by end-user
‧ Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022
‧ CROs – Market size and forecast 2017-2022
‧ Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Americas – Market size and forecast 2017-2022
‧ EMEA – Market size and forecast 2017-2022
‧ APAC – Market size and forecast 2017-2022
‧ Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 12: MARKET TRENDS
‧ Rise in investment in R&D
‧ Rise in production of vaccines
‧ Increasing outsourcing of analytical testing services
PART 13: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 14: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ Catalent
‧ Charles River
‧ Eurofins Scientific
‧ Merck KGaA
‧ SGS
PART 15: APPENDIX
‧ List of abbreviations
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global biopharmaceutical analytical testing services market – Market size and forecast 2017-2022 ($ mn)
Exhibit 08: Global biopharmaceutical analytical testing services market – Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Customer landscape
Exhibit 18: End-user – Market share 2017-2022 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Pharmaceutical and biotechnology companies – Year-over-year growth 2018-2022 (%)
Exhibit 22: CROs – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: CROs – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by end-user
Exhibit 25: Global biopharmaceutical analytical testing services market – Market share by geography 2017-2022 (%)
Exhibit 26: Regional comparison
Exhibit 27: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 28: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 29: Top 3 countries in Americas
Exhibit 30: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in EMEA
Exhibit 33: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in APAC
Exhibit 36: Market opportunity
Exhibit 37: Some therapeutic applications of mAbs
Exhibit 38: Exhibit 18: List of bioterrorism agents and their threat category
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Catalent overview
Exhibit 45: Catalent – Business segments
Exhibit 46: Catalent – Organizational developments
Exhibit 47: Catalent – Geographic focus
Exhibit 48: Catalent – Segment focus
Exhibit 49: Catalent – Key offerings
Exhibit 50: Vendor overview
Exhibit 51: Charles River – Business segments
Exhibit 52: Charles River – Organizational developments
Exhibit 53: Charles River – Geographic focus
Exhibit 54: Charles River – Segment focus
Exhibit 55: Charles River – Key offerings
Exhibit 56: Eurofins Scientific overview
Exhibit 57: Eurofins Scientific – Business segments
Exhibit 58: Eurofins Scientific – Organizational developments
Exhibit 59: Eurofins Scientific – Geographic focus
Exhibit 60: Eurofins Scientific – Segment focus
Exhibit 61: Eurofins Scientific – Key offerings
Exhibit 62: Merck KGaA overview
Exhibit 63: Merck KGaA – Business segments
Exhibit 64: Merck KGaA – Organizational developments
Exhibit 65: Merck KGaA – Geographic focus
Exhibit 66: Merck KGaA – Segment focus
Exhibit 67: Merck KGaA – Key offerings
Exhibit 68: SGS overview
Exhibit 69: SGS – Business segments
Exhibit 70: SGS – Organizational developments
Exhibit 71: SGS – Geographic focus
Exhibit 72: SGS – Segment focus
Exhibit 73: SGS – Key offerings
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
‧ Segmentation by end-user
‧ Comparison by end-user
‧ Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022
‧ CROs – Market size and forecast 2017-2022
‧ Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Americas – Market size and forecast 2017-2022
‧ EMEA – Market size and forecast 2017-2022
‧ APAC – Market size and forecast 2017-2022
‧ Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 12: MARKET TRENDS
‧ Rise in investment in R&D
‧ Rise in production of vaccines
‧ Increasing outsourcing of analytical testing services
PART 13: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 14: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ Catalent
‧ Charles River
‧ Eurofins Scientific
‧ Merck KGaA
‧ SGS
PART 15: APPENDIX
‧ List of abbreviations
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global biopharmaceutical analytical testing services market – Market size and forecast 2017-2022 ($ mn)
Exhibit 08: Global biopharmaceutical analytical testing services market – Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Customer landscape
Exhibit 18: End-user – Market share 2017-2022 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Pharmaceutical and biotechnology companies – Year-over-year growth 2018-2022 (%)
Exhibit 22: CROs – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: CROs – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by end-user
Exhibit 25: Global biopharmaceutical analytical testing services market – Market share by geography 2017-2022 (%)
Exhibit 26: Regional comparison
Exhibit 27: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 28: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 29: Top 3 countries in Americas
Exhibit 30: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in EMEA
Exhibit 33: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in APAC
Exhibit 36: Market opportunity
Exhibit 37: Some therapeutic applications of mAbs
Exhibit 38: Exhibit 18: List of bioterrorism agents and their threat category
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Catalent overview
Exhibit 45: Catalent – Business segments
Exhibit 46: Catalent – Organizational developments
Exhibit 47: Catalent – Geographic focus
Exhibit 48: Catalent – Segment focus
Exhibit 49: Catalent – Key offerings
Exhibit 50: Vendor overview
Exhibit 51: Charles River – Business segments
Exhibit 52: Charles River – Organizational developments
Exhibit 53: Charles River – Geographic focus
Exhibit 54: Charles River – Segment focus
Exhibit 55: Charles River – Key offerings
Exhibit 56: Eurofins Scientific overview
Exhibit 57: Eurofins Scientific – Business segments
Exhibit 58: Eurofins Scientific – Organizational developments
Exhibit 59: Eurofins Scientific – Geographic focus
Exhibit 60: Eurofins Scientific – Segment focus
Exhibit 61: Eurofins Scientific – Key offerings
Exhibit 62: Merck KGaA overview
Exhibit 63: Merck KGaA – Business segments
Exhibit 64: Merck KGaA – Organizational developments
Exhibit 65: Merck KGaA – Geographic focus
Exhibit 66: Merck KGaA – Segment focus
Exhibit 67: Merck KGaA – Key offerings
Exhibit 68: SGS overview
Exhibit 69: SGS – Business segments
Exhibit 70: SGS – Organizational developments
Exhibit 71: SGS – Geographic focus
Exhibit 72: SGS – Segment focus
Exhibit 73: SGS – Key offerings
